Cargando…
Duchenne Muscular Dystrophy Patients: Troponin Leak in Asymptomatic and Implications for Drug Toxicity Studies
BACKGROUND: Cardiomyopathy is the leading cause of death in Duchenne Muscular Dystrophy (DMD), but studies suggest heart failure biomarkers correlate poorly with cardiomyopathy severity. DMD clinical trials have used troponin I (cTnI) as a biomarker of toxicity but it is unclear if asymptomatic DMD...
Autores principales: | Sheybani, Aryaz, Crum, Kim, Raucci, Frank J, Burnette, William B, Markham, Larry W, Soslow, Jonathan H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866537/ https://www.ncbi.nlm.nih.gov/pubmed/34429516 http://dx.doi.org/10.1038/s41390-021-01682-5 |
Ejemplares similares
-
Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy
por: Arteaga, David, et al.
Publicado: (2020) -
Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy
por: Raucci, Frank J., et al.
Publicado: (2021) -
T1 mapping is abnormal before decline in EF in patients with Becker and Duchenne muscular dystrophy
por: Soslow, Jonathan H, et al.
Publicado: (2013) -
Myocardial strain imaging in Duchenne muscular dystrophy
por: Earl, Conner C., et al.
Publicado: (2022) -
Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores
por: Soslow, Jonathan H., et al.
Publicado: (2017)